Michael McCaughan
When Big Pharma executives looked at House Speaker Nancy Pelosi’s agenda for 2007, they didn’t see this coming.
With Enemies Like These: Will the Democrats Make Part D More Pharma Friendly?
The Democratic leadership rammed a major health bill through the House this summer, including some Medicare Part D fixes that read like a Big Pharma wish list. Have the industry's toughest critics gone soft?